Market Place
Sourcing Support
Breckenridge Launches Tofacitinib Tablets, Generic of Xeljanz®
04 Jun 2026 //
PRESS RELEASE
Towa International Promotes Debate on Generic Medicines
13 May 2026 //
PRESS RELEASE
Towa welcomes Minister Hereu, backs generics for Spain`s NHS
27 Apr 2026 //
PRESS RELEASE
Catalonia`s Business Minister visits Towa International HQ
14 Apr 2026 //
PRESS RELEASE
Breckenridge launches Milnacipran HCl, generic of Savella
19 Mar 2026 //
PRESS RELEASE
Towa Cuts Water Use 35,000 M³; Targets 40% Efficiency by 2030
18 Mar 2026 //
PRESS RELEASE
EU Councilor Jaume Duch Visits Towa International HQ
10 Mar 2026 //
PRESS RELEASE
Breckenridge Launches Pomalidomide Capsules for Oncology
02 Mar 2026 //
PRESS RELEASE
Towa Receives Manufacturing & Marketing Approval for Generic Drug
16 Feb 2026 //
PRESS RELEASE
Consolidated Financial Results for the 9 Months Ended December
13 Feb 2026 //
PRESS RELEASE
FY2025(3rd quarter) Supplementary Material of Financial Results
13 Feb 2026 //
PRESS RELEASE
Breckenridge and Medichem Announce Strategic Collaboration
05 Feb 2026 //
PRESS RELEASE
Catalan Parliament Health Committee Head Visits Towa Hub
02 Feb 2026 //
PRESS RELEASE
Brand–Generic Collaboration to Secure Off-patent Drug Supply
21 Jan 2026 //
PRESS RELEASE
Towa Pharma Integrated Report 2025 has been released
22 Dec 2025 //
PRESS RELEASE
Towa International Joins Mujeres en Farma for Women`s Leadership
04 Dec 2025 //
PRESS RELEASE
Towa International Marks 5th Anniversary with €165 M Invested
26 Nov 2025 //
PRESS RELEASE
Towa FY2025(2nd Q) Supplementary Material of Financial Results
10 Nov 2025 //
PRESS RELEASE
Towa International Drives Global Connections at CPHI Frankfurt
01 Nov 2025 //
PRESS RELEASE
Breckenridge Launches Everolimus 1mg, Generic of Zortress
30 Oct 2025 //
PRESS RELEASE
Towa cuts own emissions 60% toward NetZero goal
24 Oct 2025 //
PRESS RELEASE
Towa Consolidated FYR for the Six Months Ended September 30, 2025
11 Oct 2025 //
PRESS RELEASE
Towa Pharmaceu Launched a special website "NOx ThinkTank Project
06 Oct 2025 //
PRESS RELEASE
Towa International Welcomes New AESEG Secretary General
25 Sep 2025 //
PRESS RELEASE
Towa`s Research paper on Cut nitroso-atomoxetine contamination
22 Aug 2025 //
PUBS ACS
President of Catalonia Parliament Visits Towa International
28 Jul 2025 //
PRESS RELEASE
Towa exceeds €330M revenue with 5% growth in FY2024
22 Jul 2025 //
PRESS RELEASE
Generic Medicines: A Pillar for A Sustainable Health System
07 Apr 2025 //
PRESS RELEASE
Notice of Partial Revision of Basic Policy for the Development
17 Mar 2025 //
PRESS RELEASE
Acquired approval for manufacture & marketing generic drugs
17 Feb 2025 //
PRESS RELEASE
Consolidated Financial Results for 9 Months Ended Dec 31
13 Feb 2025 //
PRESS RELEASE
Dividend Forecasts for the Fiscal Year Ending March 31, 2025
13 Feb 2025 //
PRESS RELEASE
financial results for Q3 of the year ending March 31, 202
13 Feb 2025 //
PRESS RELEASE
João Paulo Nascimento elected president of Equalmed
05 Feb 2025 //
PRESS RELEASE
Towa Pharmaceutical Integrated Report 2024
06 Jan 2025 //
PRESS RELEASE
Consolidated Financial Results for the Six Months
12 Nov 2024 //
PRESS RELEASE
FY2024 2Q Supplementary Material of Financial Results
12 Nov 2024 //
PRESS RELEASE
Notice of Revisions of Financial Forecasts
05 Nov 2024 //
PRESS RELEASE
Listing of New Products New Generics In NHI Drug Price Standard
05 Nov 2024 //
PRESS RELEASE
Towa International earns AENOR Healthy Company Certification
22 Oct 2024 //
PRESS RELEASE
Towa International Obtain Certification to Commercialize in Libya
16 Oct 2024 //
PRESS RELEASE
Towa Expands with New High Containment Area in Barcelona
26 Sep 2024 //
PRESS RELEASE
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
FY2024 Supplementary Material of Financial Results 1Q
08 Aug 2024 //
PRESS RELEASE
Towa Reinforces DEI Commitment with Social Experiment Launch
27 Jun 2024 //
PRESS RELEASE
Notice of Financial Results of Parent Company, etc.
25 Jun 2024 //
PRESS RELEASE
Towa International makes its CMO/CDMO model official
21 Jun 2024 //
PRESS RELEASE
NHI Drug Price List Updated With Three Ingredients & 7 Generics
13 Jun 2024 //
PRESS RELEASE
FY2023 Supplementary Material of Financial Results
14 May 2024 //
PRESS RELEASE
Summary of Consolidated Financial Results for the Year Ended March 31, 2024
14 May 2024 //
PRESS RELEASE
Towa Leads Sustainable Mobility with 100% EV Fleet in Portugal
07 May 2024 //
PRESS RELEASE
Towa Launches NG Precision+, All-In-One Home Pregnancy Test
18 Apr 2024 //
PRESS RELEASE
N-Nitroso Duloxetine Analytical Method Published in ACS Omega
15 Mar 2024 //
PRESS RELEASE
Towa Gains Approval to Export Magnesium Esomeprazole to Japan
01 Mar 2024 //
PRESS RELEASE
Manufacturing and Marketing Approval for Three Ingredients and Eight Items
15 Feb 2024 //
PRESS RELEASE
Approval Granted For Additional Manufacturing Plant For Esomeprazole Capsules
14 Feb 2024 //
PRESS RELEASE
FY2023 3Q Supplementary Material of Financial Results
13 Feb 2024 //
PRESS RELEASE
Towa Signs Power Purchase Agreement with Axpo Iberia
19 Dec 2023 //
PRESS RELEASE
Saynor and Gupta named IGBA CEO Advisory Committee Chair/VC
31 Oct 2023 //
PRESS RELEASE
Stem Cells Could Help Uncover New Uses for Drugs
16 Feb 2023 //
PRESS RELEASE
